Dataset Information

Aging and APOE-ε4 are determinative factors of plasma Aβ42 levels.

ABSTRACT:

Objective

The aim of this study was to confirm determinative factors for plasma Aβ and its association with cognitive function.

Methods

Fasting plasma Aβ40 and Aβ42 levels were measured by ELISA in 1019 participants in the Iwaki Health Promotion Project. The relationships between plasma Aβ and health-related items, including physical characteristics, cognitive function tests, blood chemistry, and APOE-ε4 genotype were analyzed.

Results

The plasma levels of Aβ40 and Aβ42, and Aβ40/42 ratio were found to significantly increase with aging. The age-dependent increase in Aβ42 level was significantly suppressed by APOE-ε4. Renal function was an associated factor for the plasma Aβ40 level. The plasma Aβ42 level and Aβ40/42 ratio correlated with cognitive function.

Interpretation

Age and APOE-ε4 are major determinative factors of plasma levels of Aβ42 and the Aβ40/42 ratio. These factors are critical adjustment factors for the usage of plasma Aβ as a biomarker of central nervous system amyloidosis.

SUBMITTER: Nakamura T

PROVIDER: S-EPMC6186936 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Aging and <i>APOE-ε4</i> are determinative factors of plasma A<i>β</i>42 levels.

Nakamura Takumi T Kawarabayashi Takeshi T Seino Yusuke Y Hirohata Mie M Nakahata Naoko N Narita Sakiko S Itoh Ken K Nakaji Shigeyuki S Shoji Mikio M

Annals of clinical and translational neurology 20180907 10

<h4>Objective</h4>The aim of this study was to confirm determinative factors for plasma A<i>β</i> and its association with cognitive function.<h4>Methods</h4>Fasting plasma A<i>β</i>40 and A<i>β</i>42 levels were measured by ELISA in 1019 participants in the Iwaki Health Promotion Project. The relationships between plasma A<i>β</i> and health-related items, including physical characteristics, cognitive function tests, blood chemistry, and <i>APOE-ε4</i> genotype were analyzed.<h4>Results</h4>The ...[more]

PMID: 30349853

Similar Datasets

Project description:BackgroundCerebrospinal fluid (CSF) biomarkers Aβ1-42, t-tau and p-tau have a characteristic pattern in Alzheimer's Disease (AD). Their roles in HIV-associated neurocognitive disorder (HAND) remains unclear.MethodsAdults with chronic treated HIV disease were recruited (n = 43, aged 56.7 ± 7.9; 32% aged 60+; median HIV duration 20 years, >95% plasma and CSF HIV RNA <50 cp/mL, on cART for a median 24 months). All underwent standard neuropsychological testing (61% had HAND), APOE genotyping (30.9% carried APOE ε4 and 7.1% were ε4 homozygotes) and a lumbar puncture. Concentrations of Aβ1-42, t-tau and p-tau were assessed in the CSF using commercial ELISAs. Current neurocognitive status was defined using the continuous Global Deficit Score, which grades impairment in clinically relevant categories. History of HAND was recorded. Univariate correlations informed multivariate models, which were corrected for nadir CD4-T cell counts and HIV duration.ResultsCarriage of APOE ε4 predicted markedly lower levels of CSF Aβ1-42 in univariate (r = -.50; p = .001) and multivariate analyses (R(2) = .25; p < .0003). Greater levels of neurocognitive impairment were associated with higher CSF levels of p-tau in univariate analyses (r = .32; p = .03) and multivariate analyses (R(2) = .10; p = .03). AD risk prediction cut-offs incorporating all three CSF biomarkers suggested that 12.5% of participants had a high risk for AD. Having a CSF-AD like profile was more frequent in those with current (p = .05) and past HIV-associated dementia (p = .03).ConclusionsSimilarly to larger studies, APOE ε4 genotype was not directly associated with HAND, but moderated CSF levels of Aβ1-42 in a minority of participants. In the majority of participants, increased CSF p-tau levels were associated with current neurocognitive impairment. Combined CSF biomarker risk for AD in the current HIV+ sample is more than 10 times greater than in the Australian population of the same age. Larger prospective studies are warranted.